TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34350491

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) in addition to prednisolone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 15
Study: 34728250

Group type: EXPERIMENTAL
Intervention: TAU augmented with the 5-min FoodT app daily for 4 weeks (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU; n = 40)
Number of subjects: 80
Study: 33594922

Group type: EXPERIMENTAL
Intervention: LNG-IUD
Number of subjects: 60

Group type: COMPARATOR
Intervention: Copper-IUD
Number of subjects: 60
Study: 33491367

Group type: EXPERIMENTAL
Intervention: Conical Standard (CS) implants
Number of subjects: 33

Group type: COMPARATOR
Intervention: Internal Hex (IH) implants
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: CS implants
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: CS and IH implants
Number of subjects: 33
Study: 34515098

Group type: EXPERIMENTAL
Intervention: Thulium laser (L)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined L-PDT
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study: 34126564

Group type: EXPERIMENTAL
Intervention: NIO-P
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: EZ-IO
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Jamshidi needle
Number of subjects: 65

Group type: COMPARATOR
Intervention: IV access
Number of subjects: 65
Study: 32796401

Group type: EXPERIMENTAL
Intervention: S. boulardii CNCM I‐3799 (5 billion CFU twice daily for 5 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: S. boulardii CNCM I‐3799
Number of subjects: 100
Study: 36027758

Group type: EXPERIMENTAL
Intervention: Living Peace Intervention (LPint)
Number of subjects: 1736

Group type: COMPARATOR
Intervention: Control (villages affected by conflict)
Number of subjects: 1736
Study: 33690202

Group type: EXPERIMENTAL
Intervention: Addition of ascorbic acid (vitamin C) standards (spikes) into isolated samples
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (samples without vitamin C spikes)
Number of subjects: 30
Study: 32956178

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) monotherapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Combination therapy (CT)
Number of subjects: 55
Study: 34730813

Group type: EXPERIMENTAL
Intervention: Sources of Meaning Card Method (SoMeCaM) with standard care
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 42
Study: 34349376

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 90
Study: 33060496

Group type: EXPERIMENTAL
Intervention: Guided imagery along with breathing relaxation
Number of subjects: 90
Study: 33687633

Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral intervention (SHARE project)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivational interviewing calls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partner support
Number of subjects: 0
Study: 33190860

Group type: EXPERIMENTAL
Intervention: SuperSeal desensitizer with shockwave (Group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: SuperSeal desensitizer only (Group 1)
Number of subjects: 20
Study: 35664552

Group type: EXPERIMENTAL
Intervention: Standardized patient case simulation
Number of subjects: 286
Study: 33758069

Group type: EXPERIMENTAL
Intervention: Delayed prognostication scores calculated on day 4 (oICH, MICH, max-ICH)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Baseline prognostication scores (oICH, MICH, max-ICH)
Number of subjects: 276
Study: 32415824

Group type: EXPERIMENTAL
Intervention: Yogic visual concentration (Trataka)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine activities (Control)
Number of subjects: 0
Study: 35533876

Group type: EXPERIMENTAL
Intervention: 1-year home-based gardening intervention, individually mentored by extension-certified master gardeners
Number of subjects: 381

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 381
Study: 32851876

Group type: EXPERIMENTAL
Intervention: BUP-NX (sublingual buprenorphine-naloxone)
Number of subjects: 334

Group type: COMPARATOR
Intervention: XR-NTX (extended-release injection naltrexone)
Number of subjects: 334
Study: 36004376

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 100
Study: 32646362

Group type: EXPERIMENTAL
Intervention: Symbiter-Smectite
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 35110415

Group type: EXPERIMENTAL
Intervention: Enzalutamide plus mifepristone
Number of subjects: 106

Group type: COMPARATOR
Intervention: Enzalutamide alone
Number of subjects: 106
Study: 33453783

Group type: EXPERIMENTAL
Intervention: Advanced hybrid closed-loop system
Number of subjects: 113

Group type: COMPARATOR
Intervention: MiniMed 670G hybrid closed-loop system
Number of subjects: 113
Study: 36314399

Group type: EXPERIMENTAL
Intervention: Propped/prone positioning
Number of subjects: 68

Group type: COMPARATOR
Intervention: Feed-rate intervention (continuous pump feeds)
Number of subjects: 68
Study: 36200798

Group type: COMPARATOR
Intervention: Minority patients (Black, Asian, Hispanic)
Number of subjects: 465
Study: 32680781

Group type: EXPERIMENTAL
Intervention: Telephonic motivational interviewing (MoI) intervention
Number of subjects: 456

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 456
Study: 34761530

Group type: EXPERIMENTAL
Intervention: Information sheets given to participants with diabetes and their spouses (dyad group)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Information sheet given only to participants with diabetes (individual group)
Number of subjects: 133
Study: 34619894

Group type: EXPERIMENTAL
Intervention: Immediate rehabilitation by using implant-supported full-arch prostheses (TG)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Immediate rehabilitation of implant-supported full-arch prostheses (CG)
Number of subjects: 104
Study: 35149373

Group type: EXPERIMENTAL
Intervention: Music medicine
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 33497854

Group type: EXPERIMENTAL
Intervention: Online hazard perception training course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34146512

Group type: EXPERIMENTAL
Intervention: Pioglitazone (0.8 mg/day sustained release)
Number of subjects: 3494

Group type: COMPARATOR
Intervention: Placebo (high risk)
Number of subjects: 3494

Group type: COMPARATOR
Intervention: Placebo (low risk)
Number of subjects: 3494

Group type: EXPERIMENTAL
Intervention: Pioglitazone (high risk)
Number of subjects: 3494
Study: 33271893

Group type: EXPERIMENTAL
Intervention: Eating habits and dietary practices among students
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Barriers to adherence to healthy eating
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Awareness of healthy diets
Number of subjects: 564
Study: 35606100

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD-MTX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34606758

Group type: EXPERIMENTAL
Intervention: Tablet administration of FAMCAT
Number of subjects: 300

Group type: COMPARATOR
Intervention: Interview administration of FAMCAT
Number of subjects: 300
Study: 33063308

Group type: EXPERIMENTAL
Intervention: Creative Strengthening Groups
Number of subjects: 366

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 366
Study: 34988564

Group type: EXPERIMENTAL
Intervention: Riceberry rice beverage (RRB) with HCMF meal (2 g of riceberry rice extract powder/400 ml)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Riceberry rice beverage (RRB) with HCMF meal
Number of subjects: 13

Group type: COMPARATOR
Intervention: HCMF meal without RRB
Number of subjects: 13

Group type: COMPARATOR
Intervention: HCMF meal with or without RRB
Number of subjects: 13
Study: 33788326

Group type: EXPERIMENTAL
Intervention: Complete harm reduction program (HRP) participation (≥ 60 mg/day methadone and 100% needle and syringe program coverage)
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Complete harm reduction program (HRP) participation
Number of subjects: 983

Group type: COMPARATOR
Intervention: No HRP and partial HRP participation (< 60 mg/day methadone and/or < 100% NSP coverage)
Number of subjects: 983
Study: 32381925

Group type: EXPERIMENTAL
Intervention: L-carnitine oral supplements (group C)
Number of subjects: 1

Group type: COMPARATOR
Intervention: No L-carnitine oral supplements (group N)
Number of subjects: 1
Study: 36384737

Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg once daily for 10 days
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Prednisolone and Placebo (both groups performed olfactory training)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Prednisolone and Placebo
Number of subjects: 115
Study: 32164675

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate (GFF)
Number of subjects: 1943
Study: 36409058

Group type: EXPERIMENTAL
Intervention: Sodium chloride (1 g/d) as an add-on to lithium carbonate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lithium carbonate with advice not to take additional salt
Number of subjects: 60
Study: 34459406

Group type: EXPERIMENTAL
Intervention: Genetically predicted coffee consumption (cups/day)
Number of subjects: 447516

Group type: EXPERIMENTAL
Intervention: Genetically predicted 50% increase of coffee consumption
Number of subjects: 447516
Study: 32839028

Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Simulation from previously established FPG model
Number of subjects: 70
Study: 33301740

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy over a maximum of 8 days) followed by six cycles of CAPOX chemotherapy or nine cycles of FOLFOX4, followed by total mesorectal excision.
Number of subjects: 912

Group type: COMPARATOR
Intervention: Standard of care: 28 daily fractions of 1.8 Gy up to 50.4 Gy or 25 fractions of 2.0 Gy up to 50.0 Gy with concomitant capecitabine 825 mg/m2, followed by total mesorectal excision and optional adjuvant chemotherapy.
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 912

Group type: COMPARATOR
Intervention: Standard of care group
Number of subjects: 912
Study: 32918486

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 0
Study: 35727393

Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 500 mJ and 15 Hz
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 300 mJ and 15 Hz
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 400 mJ and 15 Hz
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 9.6% hydrofluoric acid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 34254189

Group type: EXPERIMENTAL
Intervention: Insoluble oat hulls fibre supplement
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 180
Study: 32532035

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs enriched hen eggs (1053 mg n-3 PUFAs/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Regular hen eggs (249 mg n-3 PUFAs/day)
Number of subjects: 38
Study: 36069928

Group type: EXPERIMENTAL
Intervention: Bihormonal artificial pancreas (BIHAP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Current diabetes care (insulin pump or pen therapy)
Number of subjects: 12
Study: 33963722

Group type: EXPERIMENTAL
Intervention: 0.2 μg · kg‐1·h‐1 DEX
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.5 μg · kg‐1·h‐1 DEX
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.8 μg · kg‐1·h‐1 DEX
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 120
Study: 36238824

Group type: EXPERIMENTAL
Intervention: Closed reduction and internal fixation with hollow nails
Number of subjects: 90

Group type: COMPARATOR
Intervention: Open reduction and internal fixation with hollow nails
Number of subjects: 90
Study: 32072269

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT)
Number of subjects: 0
Study: 33025006

Group type: EXPERIMENTAL
Intervention: Warm rice (14 mg · kg‐1 · d‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cold rice (14 mg · kg‐1 · d‐1)
Number of subjects: 6
Study: 35905573

Group type: EXPERIMENTAL
Intervention: Triamcinolone Hexacetonide + Lidocaine (TH/LD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lidocaine (LD)
Number of subjects: 60
Study: 32758058

Group type: EXPERIMENTAL
Intervention: Leucine (1.11 g) + Resveratrol (50 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 35822931

Group type: EXPERIMENTAL
Intervention: Specific Task and Splint Group
Number of subjects: 33

Group type: COMPARATOR
Intervention: Comparison Group
Number of subjects: 33
Study: 33303111

Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: PFO closure (in thrombophilia subgroup)
Number of subjects: 591

Group type: COMPARATOR
Intervention: Medical therapy (in thrombophilia subgroup)
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Thrombophilia
Number of subjects: 591
Study: 35587070

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine and propolis (NACp) 600 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine and propolis (NACp) 1200 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33848070

Group type: EXPERIMENTAL
Intervention: Parasacral TENS administered twice weekly
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Parasacral TENS administered three times weekly
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bladder diary evaluation for both groups
Number of subjects: 34
Study: 34147954

Group type: EXPERIMENTAL
Intervention: SCM stretching and massage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physiotherapy (CG)
Number of subjects: 60
Study: 35431898

Group type: EXPERIMENTAL
Intervention: Auditory-Cognitive Training (AC training; n = 13)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Auditory Training (A training; n = 13)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cognitive Training (C training; n = 14)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active Control (n = 12)
Number of subjects: 50
Study: 33019888

Group type: COMPARATOR
Intervention: Usual care (direct usual care aphasia therapy)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: High intensity group (usual care-plus or prescribed direct aphasia therapy)
Number of subjects: 246
Study: 35409964

Group type: EXPERIMENTAL
Intervention: EMPWR intervention
Number of subjects: 301
Study: 33771104

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy plus guideline directed therapy (BAT + GDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guideline directed therapy (GDT) alone
Number of subjects: 0
Study: 32252739

Group type: EXPERIMENTAL
Intervention: Individualized coaching for 18 months (n=186)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard care (n=194)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Individualized coaching
Number of subjects: 380

Group type: COMPARATOR
Intervention: Individualized coaching and Standard care
Number of subjects: 380
Study: 36304830

Group type: EXPERIMENTAL
Intervention: Sugar-free apricot jam with white bread (JWB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cocoa with fat-free milk (CM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dried cranberry cereal bar (CB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: White bread (WB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: d-glucose
Number of subjects: 12
Study: 35370914

Group type: EXPERIMENTAL
Intervention: Optimized acupuncture and moxibustion treatment (OAMT), given five times per week for 4 weeks.
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 134
Study: 35779599

Group type: EXPERIMENTAL
Intervention: Leaflet resection strategy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Leaflet preservation strategy
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Elevated gradients
Number of subjects: 104
Study: 36329513

Group type: EXPERIMENTAL
Intervention: Treamid 50 mg once a day for 4 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 32927285

Group type: EXPERIMENTAL
Intervention: Apomorphine sublingual film (APL) titration (10–35 mg)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Apomorphine sublingual film (APL)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Carbidopa/levodopa (CD/LD)
Number of subjects: 141
Study: 36279409

Group type: EXPERIMENTAL
Intervention: Norepinephrine at a starting rate of 0.05 μg·kg‐1·min‐1 (n = 62)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Phenylephrine at a starting rate of 0.5 μg·kg‐1·min‐1 (n = 62)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Phenylephrine group
Number of subjects: 124

Group type: COMPARATOR
Intervention: Phenylephrine group (excluding parturients with gestational diabetes)
Number of subjects: 124
Study: 33646860

Group type: EXPERIMENTAL
Intervention: Ketone monoester (KE) supplement (600 mg/kg body mass)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 32763450

Group type: EXPERIMENTAL
Intervention: Enhanced steering system
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional steering system
Number of subjects: 14
Study: 33128085

Group type: EXPERIMENTAL
Intervention: Immunohistochemical panel (eight antibodies)
Number of subjects: 187
Study: 32868483

Group type: EXPERIMENTAL
Intervention: IPACK block
Number of subjects: 119

Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 119
Study: 35697592

Group type: EXPERIMENTAL
Intervention: Infrared filter film with 75% visible light transmission and 90% infrared rejection
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no infrared filter film)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Infrared filter film
Number of subjects: 44
Study: 35752716

Group type: EXPERIMENTAL
Intervention: Phacoviscocanalostomy (n = 45)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Phacoemulsification alone (n = 44)
Number of subjects: 89
Study: 34404294

Group type: EXPERIMENTAL
Intervention: Elite players
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-division players
Number of subjects: 68
Study: 33024990

Group type: EXPERIMENTAL
Intervention: 9.3 wt% protein concentration milk
Number of subjects: 12

Group type: COMPARATOR
Intervention: 3.1 wt% protein concentration milk
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40:60 casein to whey ratio milk
Number of subjects: 12

Group type: COMPARATOR
Intervention: 80:20 casein to whey ratio milk
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All treatments pooled
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pre-lunch BG
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post-lunch BG
Number of subjects: 12
Study: 35075216

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 99
Study: 32920022

Group type: EXPERIMENTAL
Intervention: 100 mg of enteric-coated aspirin daily
Number of subjects: 4758

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4758
Study: 34244805

Group type: EXPERIMENTAL
Intervention: High-intensity treadmill exercise
Number of subjects: 110

Group type: COMPARATOR
Intervention: Moderate-intensity treadmill exercise
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 110
Study: 32497586

Group type: COMPARATOR
Intervention: Interval Running (IR)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Small-Sided Games (SSG)
Number of subjects: 232
Study: 33907782

Group type: EXPERIMENTAL
Intervention: Multi-dimensional oral cleaning intervention model
Number of subjects: 600

Group type: COMPARATOR
Intervention: Routine oral health education (Control)
Number of subjects: 600
Study: 33899509

Group type: EXPERIMENTAL
Intervention: QFR ≤0.80
Number of subjects: 617

Group type: COMPARATOR
Intervention: QFR >0.80
Number of subjects: 617
Study: 35437114

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 0
Study: 33388951

Group type: EXPERIMENTAL
Intervention: Glasdegib (100 mg, oral, fasted conditions)
Number of subjects: 18
Study: 32981242

Group type: EXPERIMENTAL
Intervention: Bacillus isolate B-27
Number of subjects: 0
Study: 35493937

Group type: EXPERIMENTAL
Intervention: Anodal-tDCS (atDCS) + Working Memory Training (WMT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham-tDCS (stDCS) + Working Memory Training (WMT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Double-sham
Number of subjects: 54
Study: 34183579

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus rhamnosus GG and a combination probiotic: L. rhamnosus and L. helveticus)
Number of subjects: 1770

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 1770
Study: 35674861

Group type: EXPERIMENTAL
Intervention: Ixekizumab monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ixekizumab with methotrexate (MTX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ixekizumab with any csDMARD (including MTX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ixekizumab with MTX
Number of subjects: 0
Study: 34219510

Group type: EXPERIMENTAL
Intervention: Reach training plus usual care
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 38
Study: 32127191

Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 0
Study: 34738687

Group type: EXPERIMENTAL
Intervention: Stop-tabac application
Number of subjects: 5293

Group type: COMPARATOR
Intervention: Control application
Number of subjects: 5293
Study: 33765581

Group type: EXPERIMENTAL
Intervention: EAE food supplement (500 mg daily for 6 months)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 35980787

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 74